Respiratory solutions provider VARON announced on Tuesday that it is expanding access to home oxygen concentrators.
The company said that this expansion is intended to help individuals with respiratory conditions maintain independence and an active lifestyle.
By providing flexible, user-friendly options, VARON ensures respiratory support is tailored to real-life needs, helping individuals breathe easier without limitations.
VARON offers a range of home and portable oxygen concentrators designed to fit different lifestyles. Its home oxygen concentrators are designed for long-term, stable oxygen support, while portable devices help users maintain active routines without sacrificing independence.
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA
Qlife secures UK approval to initiate clinical trial for Egoo Phe System
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
Femasys receives CE mark approval for FemBloc delivery system in Europe
Avance Biosciences registers with CLIA program
Abbott announces quarterly common dividend
Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe
Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan